Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4240830 | Journal of Vascular and Interventional Radiology | 2010 | 6 Pages |
Abstract
Lobaplatin-based chemoembolization may elicit effective tumor response for recurrent HCCs and improve the overall survival of patients with unresectable HCC recurrence following OLT.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Bin MD, Hong MD, Kang-Shun MD, Zai-Bo MD, Shou-Hai MD, Xiao-Chun MD, Xian-Cheng MD,